Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study
International Journal of Chronic Obstructive Pulmonary Disease · 2025
DOI: 10.2147/copd.s495086 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025. Verfasst von Gaétan Deslee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pneumologie, INSERM UMRS-1250, Centre Hospitalier Universitaire de Reims, Université Reims, Champagne-Ardenne, France. Hauptthemen laut MEDLINE: Adrenergic beta-2 Receptor Agonists, Bronchodilator Agents, Budesonide, Budesonide, Formoterol Fumarate Drug Combination. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Pneumologie, INSERM UMRS-1250, Centre Hospitalier Universitaire de Reims, Université Reims, Champagne-Ardenne, France.
- AstraZeneca, Courbevoie, France.
- Cegedim Group, Boulogne-Billancourt, France.
- Department of Applied Health Sciences, University of Birmingham, Edgbaston, Birmingham, UK.
- Public Health Expertise, Paris, Île-de-France, France.
ORCID-Profile: Gaétan Deslee, Caroline Fabry-Vendrand, Nicola J Adderley
Zitieren
APA
Deslee, G., Fabry-Vendrand, C., Salmi, E., Poccardi, N., Coriat, A., Ghout, I., Eteve-Pitsaer, C., Adderley, N. J., & Leleu, H. (2025). Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s495086
Vancouver
Deslee G, Fabry-Vendrand C, Salmi E, Poccardi N, Coriat A, Ghout I, et al. Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study. International Journal of Chronic Obstructive Pulmonary Disease. 2025. doi:10.2147/copd.s495086
BibTeX
@article{Deslee2025,
author = {Deslee, Gaétan and Fabry-Vendrand, Caroline and Salmi, Elsa and Poccardi, Nolwenn and Coriat, Adrien and Ghout, Idir and Eteve-Pitsaer, Caroline and Adderley, Nicola J and Leleu, Henri},
title = {Characteristics of Patients Initiated on Budesonide/Glycopyrronium Bromide/Formoterol Fumarate Single Inhaler Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Population-Based Observational Study},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2025},
doi = {10.2147/copd.s495086}
}
EUVIMED